Measurement of Receptor Signaling Bias
Current Protocols in Pharmacology · 2016-09 · 74 (1)
DOI: 10.1002/cpph.11 ↗At a glance
Journal article in Current Protocols in Pharmacology, published online on 2016-09-16. Written by Terry Kenakin. Institution: Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Major MEDLINE topics: Drug Discovery, Signal Transduction. Cited 12 times so far (Crossref); 35 references.
Abstract (original language)
G protein–coupled receptors (GPCRs) are often pleiotropically linked to numerous cellular signaling mechanisms in cells, and it is now known that many agonists differentially activate some signaling pathways at the expense of others. The mechanism for this effect is the stabilization of different active receptor states by different agonists, and it leads to varying qualities of efficacy for different agonists. Agonist bias is a powerful mechanism to amplify beneficial signals and diminish harmful signals, and thus improve the overall profile of agonist ligands. This unit describes a method to quantify agonist bias with a scale that enables medicinal chemists to amplify or reduce these effects in new molecules. The method is based on the Black/Leff operational model and yields a statistical estimate of the confidence for bias measurements. © 2016 by John Wiley & Sons, Inc.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Cite
APA
Kenakin, T. (2016). Measurement of Receptor Signaling Bias. Current Protocols in Pharmacology, 74(1). https://doi.org/10.1002/cpph.11
Vancouver
Kenakin T. Measurement of Receptor Signaling Bias. Current Protocols in Pharmacology. 2016;74(1). doi:10.1002/cpph.11
BibTeX
@article{Kenakin2016,
author = {Kenakin, Terry},
title = {Measurement of Receptor Signaling Bias},
journal = {Current Protocols in Pharmacology},
year = {2016},
volume = {74},
number = {1},
doi = {10.1002/cpph.11}
}
EUVIMED